Clinical Trials
575 trialsA Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.
BioXcel Therapeutics Inc
ISOMAB
University Hospital, Bordeaux
Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas
Grupo Espanol de Tumores Neuroendocrinos
Effect of Foot Bath on Anxiety and Physiological Parameters
Trakya University
MisterFIt
McGill University Health Centre/Research Institute of the McGill University Health Centre
LuPARP
Vastra Gotaland Region
Co-creation of Tools for Men With Suicidal Thoughts and/or Behavior
University Ghent
ALPINIST
Novartis
HYPOADENO
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
FIRST
Centre Hospitalier Universitaire de Nice
MERAIODE
Gustave Roussy, Cancer Campus, Grand Paris
Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome
Crinetics Pharmaceuticals Inc.
Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer
M.D. Anderson Cancer Center
A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
PHEO
University Hospital, Rouen
MAPS
University of California, Los Angeles
Diagnostic Performances of Urine and Plasma 5-hydroxyindolacetic Acid (5HIAA) Values in Patients With Small-intestine Neuroendocrine Tumors
CHU de Reims
Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer
University of Washington
ArTisaN
Imperial College London
Phase II Study of Pembrolizumab and Lenvatinib in Advanced Well-differentiated Neuroendocrine Tumors
H. Lee Moffitt Cancer Center and Research Institute
MIBG for Refractory Neuroblastoma and Pheochromocytoma
Masonic Cancer Center, University of Minnesota
Clinical Study of AL2846 Capsule in the Treatment of Differentiated Thyroid Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
MGMT-NET
Hospices Civils de Lyon
VESALIUS-CV
Amgen
Study of Spermatogenesis Suppression With DMAU Alone or With LNG Versus Placebo Alone in Normal Men
Premier Research
RESCUE
Sparrow Pharmaceuticals
An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer
Sanofi
Open-label Study of Surufatinib in Japanese Patients
Hutchmed
DeLLpro-300
Amgen
Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers
Memorial Sloan Kettering Cancer Center
A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072
Ariceum Therapeutics GmbH
BEVANEC
Hospices Civils de Lyon
Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)
Academic and Community Cancer Research United
Dabrafenib With or Without Trametinib in Treating Patients With Advanced Differentiated Thyroid Cancer
Ohio State University Comprehensive Cancer Center
A Gender and Culturally Specific Approach to Reduce NAFLD in Mexican-American Men
University of Arizona
Sprix
The Cleveland Clinic
68Ga-DOTATATE PET-CT for Diagnosis of Neuroendocrine Tumors (NETs)
Radio Isotope Therapy of America
Microwave Ablation and Surgical Resection for Micropapillary Thyroid Carcinoma
Chinese PLA General Hospital
Cabozantinib S-malate in Treating Patients With Metastatic Pheochromocytomas or Paragangliomas That Cannot Be Removed by Surgery
M.D. Anderson Cancer Center
METALLICA
MedSIR
TALENT
Grupo Espanol de Tumores Neuroendocrinos
Electroacupuncture and Pelvic Floor Muscle Training for Male Stress Urinary Incontinence
RenJi Hospital
GRACE
Corcept Therapeutics
A Study to Learn How Elinzanetant Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Kidneys That do Not Work as Well as They Should Compared to Participants Whose Kidneys Work Normally
Bayer
Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors
PharmaMar
68-Ga-labeled Octreotide Analogues PET in Duodenal-pancreatic Neuroendocrine Tumours
Azienda USL Reggio Emilia - IRCCS
A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b
Nuvation Bio Inc.
MIMETIC
University Medical Center Groningen
CABATEN
Grupo Espanol de Tumores Neuroendocrinos
Comparison of Postoperative Recovery of Sevoflurane and Propofol After Transsphenoidal Surgery
Peking Union Medical College Hospital